Schizophrenia Research

Article	Citations
Language as a biomarker for psychosis: A natural language processing approach	100
The role of the gut microbiome in the development of schizophrenia	68
Thalamus-related anomalies as candidate mechanism-based biomarkers for psychosis	59
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk	48
Changes of psychotic-like experiences and their association with anxiety/depression among young adolescents before COVID-19 and after the lockdown in China	48
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies	46
Gut microbiome in serious mental illnesses: A systematic review and critical evaluation	45
Going deep into schizophrenia with artificial intelligence	45
Neurodegenerative model of schizophrenia: Growing evidence to support a revisit	44
North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description	44
Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis	42
Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population	40
Lower speech connectedness linked to incidence of psychosis in people at clinical high risk	40
Everything is connected: Inference and attractors in delusions	38
Resting-state functional connectivity predictors of treatment response in schizophrenia – A systematic review and meta-analysis	37
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features	36
Accelerated aging in the brain, epigenetic aging in blood, and polygenic risk for schizophrenia	34
Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences	34
The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies	34
Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment	33
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls	33
Mapping relationships among schizophrenia, bipolar and schizoaffective disorders: A deep classification and clustering framework using fMRI time series	33
Types, prevalence and gender differences of childhood trauma in first-episode psychosis. What is the evidence that childhood trauma is related to symptoms and functional outcomes in first episode psyc	32
Gut microbial changes of patients with psychotic and affective disorders: A systematic review	32
Comparisons between suicide in persons with serious mental illness, other mental disorders, or no known mental illness: Results from 37 U.S. states, 2003–2017	32

Structural and diffusion MRI based schizophrenia classification using 2D pretrained and 3D naive Convolutional Neural Networks	32
Self-reported social functioning and social cognition in schizophrenia and bipolar disorder: Using ecological momentary assessment to identify the origin of bias	32
Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative symptoms: A randomized controlled	32
Peripheral immune markers and antipsychotic non-response in psychosis	30
Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies	30
Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis	29
Prenatal infection and schizophrenia: A decade of further progress	29
Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review	29
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people	29
P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature	29
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study	28
Real-world implementation of precision psychiatry: Transdiagnostic risk calculator for the automatic detection of individuals at-risk of psychosis	28
Gender differences in the experience of psychotic-like experiences and their associated factors: A study of adolescents from the general population	28
A network meta-analysis of psychological interventions for schizophrenia and psychosis: Impact on symptoms	28
Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review	28
What is obsession? Differentiating obsessive-compulsive disorder and the schizophrenia spectrum	28
Changes in psychotic-like experiences and related influential factors in technical secondary school and college students during COVID-19	27
The promise of layer-specific neuroimaging for testing predictive coding theories of psychosis	27
Relationships between cognitive event-related brain potential measures in patients at clinical high risk for psychosis	27
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit	27
Are we ready for a name change for schizophrenia? A survey of multiple stakeholders	27
Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis	27
Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis	26
Multiple overlapping dynamic patterns of the visual sensory network in schizophrenia	26
Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes	25
Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort	25
Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline	25
Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium	25
A systematic review of suicide and suicide attempts in adolescents with psychotic disorders	24
The oropharyngeal microbiome is altered in individuals with schizophrenia and mania	24
White matter brain aging in relationship to schizophrenia and its cognitive deficit	24
Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia	24
A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extensio	24
Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratings	24
Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders – Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial	23
Sleep disturbances and the At Risk Mental State: A systematic review and meta-analysis	23
Subclinical schizotypal vs. autistic traits show overlapping and diametrically opposed facets in a non-clinical population	23
Speech disturbances in schizophrenia: Assessing cross-linguistic generalizability of NLP automated measures of coherence	23
Rethinking delusions: A selective review of delusion research through a computational lens	23
Modeling perception and behavior in individuals at clinical high risk for psychosis: Support for the predictive processing framework	23
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature	23
Social exclusion and rejection across the psychosis spectrum: A systematic review of empirical research	23
Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia	23
A meta-analysis of social cognitive deficits in schizophrenia: Does world region matter?	23
Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition	22
Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms	22
The alliance-outcome relationship in individual psychosocial treatment for schizophrenia and early psychosis: A meta-analysis	22
Current psychotic-like experiences among adolescents in China: Identifying risk and protective factors	22
The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study	22
Dynamic causal modeling of eye gaze processing in schizophrenia	21

Changes in social functioning over the course of psychotic disorders–A meta-analysis	21
Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register	20
Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms	20
Adult outcome of preterm birth: Implications for neurodevelopmental theories of psychosis	20
Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis	20
Advanced paternal age and risk of schizophrenia in offspring – Review of epidemiological findings and potential mechanisms	20
Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study	19
Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?	19
Gender differences in the association between environment and psychosis	19
First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report	19
Interoceptive functioning in schizophrenia and schizotypy	19
Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia	18
Resilience buffers the association between sleep disturbance and psychotic-like experiences in adolescents	18
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia	18
The relationship between appraisals of voices (auditory verbal hallucinations) and distress in voice-hearers with schizophrenia-spectrum diagnoses: A meta-analytic review	18
Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study	17
The differential associations of positive and negative symptoms with suicidality	17
Investigating the diagnostic utility of speech patterns in schizophrenia and their symptom associations	17
Add on yoga treatment for negative symptoms of schizophrenia: A multi-centric, randomized controlled trial	17
The relationship between childhood abuse and severity of psychosis is mediated by loneliness: an experience sampling study	17
Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome	17
Structural covariance networks in schizophrenia: A systematic review Part I	17
Choline, folic acid, Vitamin D, and fetal brain development in the psychosis spectrum	17
Healthcare costs and resource use associated with negative symptoms of schizophrenia: A systematic literature review	17
Psychotic-like experiences from adolescence to adulthood: A longitudinal study	16
Cognitive clusters in first-episode psychosis	16
Triple network hypothesis-related disrupted connections in schizophrenia: A spectral dynamic causal modeling analysis with functional magnetic resonance imaging	16
Decreased cardiovascular death in schizophrenia patients treated with antipsychotics: A Korean national cohort study	16
Examining subjective experience of aberrant salience in young individuals at ultra-high risk (UHR) of psychosis: A 1-year longitudinal study	16
Renaming schizophrenia? A survey among psychiatrists, mental health service users and family members in Italy	16
Impact of childhood trauma on positive and negative symptom remission in first episode psychosis	16
Lower functional connectivity of white matter during rest and working memory tasks is associated with cognitive impairments in schizophrenia	16
Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness	16
A generative framework for the study of delusions	16
Proportion and characteristics of young people in a first-episode psychosis clinic who first attended an at-risk mental state service or other specialist youth mental health service	16
Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis	16
A common variation in HCN1 is associated with heart rate variability in schizophrenia	15
Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings	15
Altered expression of microglial markers of phagocytosis in schizophrenia	15
Complement C4 associations with altered microbial biomarkers exemplify gene-by-environment interactions in schizophrenia	15
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study	15
Predictors of response to pharmacological treatments in treatment-resistant schizophrenia – A systematic review and meta-analysis	15
Chronotype in individuals with schizophrenia: A meta-analysis	15
The effect of exercise on global, social, daily living and occupational functioning in people living with schizophrenia: A systematic review and meta-analysis	15
Childhood interpersonal trauma and paranoia in psychosis: The role of disorganised attachment and negative schema	15
Increased immune cell and altered microglia and neurogenesis transcripts in an Australian schizophrenia subgroup with elevated inflammation	15
Emotional and stigma-related experiences relative to being told one is at risk for psychosis	15
Sensorimotor conflicts induce somatic passivity and louden quiet voices in healthy listeners	15
Transcriptome analysis of human induced excitatory neurons supports a strong effect of clozapine on cholesterol biosynthesis	15
A comparison of stages of attention for social and nonsocial stimuli in schizophrenia: An ERP study	15
Molecular signaling pathways underlying schizophrenia	15
Cortical gray matter reduction precedes transition to psychosis in individuals at clinical high-risk for psychosis: A voxel-based meta-analysis	15
The prognosis of schizophrenia: A systematic review and meta-analysis with meta-regression of 20-year follow-up studies	15
Deep learning model using retinal vascular images for classifying schizophrenia	14
Reinventing schizophrenia. Updating the construct	14
Infections, antibiotic treatment and the Microbiome in relation to schizophrenia	14
A systematic review of social functioning outcome measures in schizophrenia with a focus on suitability for intervention research	14
Schizophrenia in the flesh: Revisiting schizophrenia as a disorder of the bodily self	14
Randomized controlled trial of an adjunctive sulforaphane nutraceutical in schizophrenia	14
Cancer rates and mortality in people with severe mental illness: Further evidence of lack of parity	14
The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in schizophrenia spectrum disorders: A systematic review	14
An observational study investigating cytokine levels in the cerebrospinal fluid of patients with schizophrenia spectrum disorders	14
Early intervention for risk syndromes: What are the real risks?	14
Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium	14
Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia	14
Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK biobank	14
Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions	14
The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease	14
Longitudinal relationships between mismatch negativity, cognitive performance, and real-world functioning in early psychosis	14
The clinical and psychosocial correlates of self-stigma among people with schizophrenia spectrum disorders across cultures: A systematic review and meta-analysis	14
The association of cannabis use with quality of life and psychosocial functioning in psychosis	13
Structural covariance networks in schizophrenia: A systematic review Part II	13
Racial microaggressions and major discriminatory events explain ethnoracial differences in psychotic experiences	13
Effect of childhood physical abuse on social anxiety is mediated via reduced frontal lobe and amygdala-hippocampus complex volume in adult clinical high-risk subjects	13
Neurobiological underpinnings of cognitive subtypes in psychoses: A cross-diagnostic cluster analysis	13
A nationwide study of the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia in Taiwan	13
Psychoeducation for individuals at clinical high risk for psychosis: A scoping review	13
Abnormal phase discontinuity of alpha- and theta-frequency oscillations in schizophrenia	13
The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples	13
Grey-matter abnormalities in clinical high-risk participants for psychosis	13

Comparison of Black and white individuals who report diagnoses of schizophrenia in a national sample of US adults: Discrimination and service use	13
Functional impairment of cortical AMPA receptors in schizophrenia	13
Mortality and non-use of antipsychotic drugs after acute admission in schizophrenia: A prospective total-cohort study	13
Distinguishing schizophrenia spectrum from non-spectrum disorders among young patients with first episode psychosis and at high clinical risk: The role of basic self-disturbance and neurocognition	13
Cognitive decline and impairment in schizophrenia spectrum disorders reconsidered	13
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments	13
The network structure of paranoia dimensions and its mental health correlates in the general population: The core role of loneliness	13
Language network self-inhibition and semantic similarity in first-episode schizophrenia: A computational-linguistic and effective connectivity approach	13
Factors and their weight in reducing life expectancy in schizophrenia	13
Validation of the Hamilton Program for Schizophrenia Voices Questionnaire: Associations with emotional distress and wellbeing, and invariance across diagnosis and sex	13
Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview	13
Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia	13
Reconceptualizing schizophrenia in the Hierarchical Taxonomy Of Psychopathology (HiTOP)	13
Neuroplasticity and inflammatory alterations in the nucleus accumbens are corrected after risperidone treatment in a schizophrenia-related developmental model in rats	13
Computerized analysis of facial expressions in serious mental illness	12
Neural correlates of disturbance in the sense of agency in schizophrenia: An fMRI study using the ‘enfacement’ paradigm	12
Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis	12
N-acetylaspartate concentration in psychotic disorders: T2-relaxation effects	12
Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders	12
Systematic review and meta-analysis: Season of birth and schizophrenia risk	12
Greater individual variability in functional brain activity during working memory performance in Schizophrenia Spectrum Disorders (SSD)	12
Childhood trauma is associated with poorer social functioning in severe mental disorders both during an active illness phase and in remission	12
Face processing of social cognition in patients with first episode psychosis: Its deficits and association with the right subcallosal anterior cingulate cortex	12
A psychological intervention for engaging dialogically with auditory hallucinations (Talking With Voices): A single-site, randomised controlled feasibility trial	12
Self-stigma in psychotic disorders: Clinical, cognitive, and functional correlates in a diverse sample	12
Induced ideas of reference during social unrest and pandemic in Hong Kong	12
Schizophrenia as a symptom of psychiatry’s reluctance to enter the moral era of medicine	12
Third external replication of an individualised transdiagnostic prediction model for the automatic detection of individuals at risk of psychosis using electronic health records	12
You say “schizophrenia” and I say “psychosis”: Just tell me when I can come off this medication	12
Subclass imbalance of parvalbumin-expressing GABAergic neurons in the hippocampus of a mouse ketamine model for schizophrenia, with reference to perineuronal nets	12
Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker	12
Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders	12
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia	12
A neurodevelopmental signature of parkinsonism in schizophrenia	12
A new 3-hit mouse model of schizophrenia built on genetic, early and late factors	12
Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study	12
Spared performance but increased uncertainty in schizophrenia: Evidence from a probabilistic decision-making task	12
Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study	12
Perceptual pathways to hallucinogenesis	11
Developmental exposure to vitamin D deficiency and subsequent risk of schizophrenia	11
Individualized prediction of 2-year risk of relapse as indexed by psychiatric hospitalization following psychosis onset: Model development in two first episode samples	11
Psychotic experiences predict subsequent loneliness among adolescents: A population-based birth cohort study	11
Gut mycobiota dysbiosis in drug-naïve, first-episode schizophrenia	11
Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort	11
The associations between area-level residential instability and gray matter volumes from the North American Prodrome Longitudinal Study (NAPLS) consortium	11
The relationship between clinical recovery and personal recovery among people living with schizophrenia: A serial mediation model and the role of disability and quality of life	11
A potential objective marker in first-episode schizophrenia based on abnormal niacin response	11
Temporal trends in psychotic symptoms: Repeated cross-sectional surveys of the population in England 2000–14	11
Spatiotemporal Psychopathology – An integrated brain-mind approach and catatonia	11
Investigating neurophysiological markers of impaired cognition in schizophrenia	11
Cerebellar and cortico-striatal-midbrain contributions to reward-cognition processes and apathy within the psychosis continuum	11
Internalizing and externalizing problems across childhood and psychotic-like experiences in young-adulthood: The role of developmental period	11
Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort	11
Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training	11
Volumetric alteration of olfactory bulb and immune-related molecular changes in olfactory epithelium in first episode psychosis patients	11
Evaluation of variability in individual response to treatments in the clinical high-risk state for psychosis: A meta-analysis	11
Mitochondrial dysfunction in psychiatric disorders	10
AMPA receptor subunit localization in schizophrenia anterior cingulate cortex	10
Computational analysis of spoken language in acute psychosis and mania	10
Systematic review and meta-analysis on predictors of prognosis in patients with schizophrenia spectrum disorders: An overview of current evidence and a call for prospective research and open access to	10
Relationship between cannabis use and psychotic experiences in college students	10
Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial	10
Aberrant expressions of MIAT and PVT1 in serum exosomes of schizophrenia patients	10
Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)	10
Effectiveness of personal recovery facilitators in adults with schizophrenia and other psychoses: A systematic review of reviews and narrative synthesis	10
Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients	10
Can antipsychotic use protect from COVID-19?	10
Perceived skin tone discrimination and psychotic experiences among Black Americans: Findings from the National Survey of American Life	10
The relationship between cognitive deficits and impaired short-term functional outcome in clinical high-risk for psychosis participants: A machine learning and modelling approach	10
Three major psychiatric disorders share specific dynamic alterations of intrinsic brain activity	10
COVID 19 vaccination of persons with schizophrenia in India – Need for imperative action!	10
Virtual Reality Therapy for the Negative Symptoms of Schizophrenia (V-NeST): A pilot randomised feasibility trial	10
Computational mechanisms underlying illusion of control in delusional individuals	10
Extended gene set analysis of human neuro-psychiatric traits shows enrichment in brain-expressed human accelerated regions across development	10
Syntactic complexity of spoken language in the diagnosis of schizophrenia: A probabilistic Bayes network model	10
Mindfulness meditation for Chinese patients with psychosis: A systematic review and meta-analysis	10
An experimental study on the effectiveness of emotion regulation in patients with acute delusions	10
Volume deficits in hippocampal subfields in unaffected relatives of schizophrenia patients with high genetic loading but without any psychiatric symptoms	10
New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus	10
Social brain network correlates with real-life social network in individuals with schizophrenia and social anhedonia	10
Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrification	10
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients	10
Psychotic experiences among Black college students in the United States: The role of socioeconomic factors and discrimination	10
Relationship between social cognition, general cognition, and risk for suicide in individuals with a psychotic disorder	10
Meta-analysis of clozapine and insomnia in schizophrenia	10
The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disor	10
Reduced neural activity when anticipating social versus nonsocial rewards in schizophrenia: Preliminary evidence from an ERP study	10
Childhood adversity and psychotic disorders: Epidemiological evidence, theoretical models and clinical considerations	10
Social exclusion in psychotic disorders: An interactional processing model	10
Unraveling the role of retrieval deficits in autobiographical memory impairment in schizophrenia: A comparison of involuntary and voluntary autobiographical memories	10
Mismatch negativity amplitude in first-degree relatives of individuals with psychotic disorders: Links with cognition and schizotypy	10
A word is worth a thousand pictures: A 20-year comparative analysis of aberrant abstraction in schizophrenia, affective psychosis, and non-psychotic depression	10
Psychotic-like experiences during COVID-19 lockdown among adolescents: Prevalence, risk and protective factors	10
The role of optogenetic stimulations of parvalbumin-positive interneurons in the prefrontal cortex and the ventral hippocampus on an acute MK-801 model of schizophrenia-like cognitive inflexibility	10
Antipsychotic-based machine learning models may help prediction of tardive dyskinesia in patients with schizophrenia	9